2023 | September / October 2023

The Evolving Role of Outsourcing in Pharmaceutical Development

by cyb2025

KEN ZREBIEC
SVP Manufacturing Operations, Veranova

ABSTRACT

As the pharmaceutical industry undergoes transformations driven by innovation, outsourcing plays a vital role in drug development. Contract development and manufacturing organizations (CDMOs) are no longer simply production capacity providers but have become integral collaborative partners. Choosing the right CDMO is crucial amid global trends and events. At Veranova, we work closely with our partners to manage industry demands with confidence. In this article, Ken Zrebiec, Veranova’s Senior VP of Manufacturing Operations, explores how pharma companies leverage specialized CDMO expertise to enhance development capabilities.

Introduction
In recent decades, the pharmaceutical industry has undergone significant changes. Driven by innovation and growth in specialized areas, more pharmaceutical companies are choosing to partner with CDMOs to obtain a competitive edge. As a result, CDMOs have become technology and innovation leaders across key stages of drug discovery, development, and manufacturing.

ABOUT THE AUTHOR

Ken Zrebiec has served as SVP, Manufacturing Operations since December 2020. With over 20 years of experience in the production of active pharmaceutical ingredients, Ken has proven leadership in site management, supply chain, project management, and environmental, health, and safety. Prior to Veranova, Ken held senior operational roles with Siegfried in the US and Switzerland and was the Director of Supply Chain at Endo Pharmaceuticals.

Ken has been on the SOCMA Board of Governors since 2018 and has been a member of the SOCMA Executive Board since 2020. Ken holds a B.S. degree in Chemical Engineering and an MBA in Operations Management from the University of Delaware.

Login